Genocea Biosciences reported $3.6M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 18.95M 3.02M
Baxter International BAX:US $ 790M 90M
Cytokinetics CYTK:US $ 33.07M 736K
Cytori Therapeutics CYTX:US $ 2.14M 99K
Genocea Biosciences GNCA:US $ 3.6M 473K
Glaxosmithkline GSK:US 2.68B 227M
Infinity Pharmaceuticals INFI:US 3.68M 413K
Merk MRK:US $ 2.3B 518M
Mirati Therapeutics MRTX:US $ 53.95M 10.42M
Moderna Inc MRNA:US 268M 67M
Novavax NVAX:US $ 95.99M 11.78M
Prothena PRTA:US 11.84M 371K